U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C15H9BrO2
Molecular Weight 301.135
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of BROMINDIONE

SMILES

BrC1=CC=C(C=C1)C2C(=O)C3=CC=CC=C3C2=O

InChI

InChIKey=NPUZIGSOEWMFKK-UHFFFAOYSA-N
InChI=1S/C15H9BrO2/c16-10-7-5-9(6-8-10)13-14(17)11-3-1-2-4-12(11)15(13)18/h1-8,13H

HIDE SMILES / InChI
Bromindione is an oral anti-coagulant derived from the monobromination of the familiar phenylindandione (Hedulin, Danilone, Dindevan).

Approval Year

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
FDA-approved drugs and other compounds tested as inhibitors of human glutathione transferase P1-1.
2013-09-05
Further studies of bromindione, a newer anticoagulant.
1967-07
Study of bromindione, a new anticoagulant.
1962-01-13
p-Bromindione: a new, potent, long-acting oral anticoagulant drug.
1961-09-09
[Anticoagulant effect of 2-(4-bromo) phenyl-1, 3-indandione (fluidemin)].
1956-10-15
Patents

Sample Use Guides

The dose range used for oral Bromindione is between 5 mg to 40 mg, with the most common dosing regime of 10 or 15 mg.
Route of Administration: Oral
In Vitro Use Guide
Unknown
Name Type Language
NSC-759118
Preferred Name English
BROMINDIONE
INN   MI   USAN  
INN   USAN  
Official Name English
BROMINDIONE [USAN]
Common Name English
BROMINDIONE [MI]
Common Name English
bromindione [INN]
Common Name English
1H-INDENE-1,3(2H)-DIONE, 2-(4-BROMOPHENYL)-
Systematic Name English
2-(P-BROMOPHENYL)-1,3-INDANDIONE
Common Name English
Code System Code Type Description
CAS
1146-98-1
Created by admin on Mon Mar 31 17:45:57 GMT 2025 , Edited by admin on Mon Mar 31 17:45:57 GMT 2025
PRIMARY
NCI_THESAURUS
C174809
Created by admin on Mon Mar 31 17:45:57 GMT 2025 , Edited by admin on Mon Mar 31 17:45:57 GMT 2025
PRIMARY
PUBCHEM
14369
Created by admin on Mon Mar 31 17:45:57 GMT 2025 , Edited by admin on Mon Mar 31 17:45:57 GMT 2025
PRIMARY
ChEMBL
CHEMBL288496
Created by admin on Mon Mar 31 17:45:57 GMT 2025 , Edited by admin on Mon Mar 31 17:45:57 GMT 2025
PRIMARY
MERCK INDEX
m2670
Created by admin on Mon Mar 31 17:45:57 GMT 2025 , Edited by admin on Mon Mar 31 17:45:57 GMT 2025
PRIMARY Merck Index
INN
1242
Created by admin on Mon Mar 31 17:45:57 GMT 2025 , Edited by admin on Mon Mar 31 17:45:57 GMT 2025
PRIMARY
FDA UNII
OQZ7BND2QN
Created by admin on Mon Mar 31 17:45:57 GMT 2025 , Edited by admin on Mon Mar 31 17:45:57 GMT 2025
PRIMARY
SMS_ID
100000088694
Created by admin on Mon Mar 31 17:45:57 GMT 2025 , Edited by admin on Mon Mar 31 17:45:57 GMT 2025
PRIMARY
EVMPD
SUB05915MIG
Created by admin on Mon Mar 31 17:45:57 GMT 2025 , Edited by admin on Mon Mar 31 17:45:57 GMT 2025
PRIMARY
DRUG CENTRAL
3037
Created by admin on Mon Mar 31 17:45:57 GMT 2025 , Edited by admin on Mon Mar 31 17:45:57 GMT 2025
PRIMARY
NSC
759118
Created by admin on Mon Mar 31 17:45:57 GMT 2025 , Edited by admin on Mon Mar 31 17:45:57 GMT 2025
PRIMARY
EPA CompTox
DTXSID8046244
Created by admin on Mon Mar 31 17:45:57 GMT 2025 , Edited by admin on Mon Mar 31 17:45:57 GMT 2025
PRIMARY
MESH
C010689
Created by admin on Mon Mar 31 17:45:57 GMT 2025 , Edited by admin on Mon Mar 31 17:45:57 GMT 2025
PRIMARY